Exact Mass: 492.2392910000001
Exact Mass Matches: 492.2392910000001
Found 500 metabolites which its exact mass value is equals to given mass value 492.2392910000001,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
rac-5,6-Epoxy-retinoyl-beta-D-glucuronide
This compound belongs to the family of Diterpene Glycosides. These are diterpenes in which an isoprene unit is glycosylated.
4-Hydroxyretinoic acid glucuronide
4-Hydroxyretinoic acid glucuronide belongs to the class of organic compounds known as diterpene glycosides. These are diterpenoids in which an isoprene unit is glycosylated.
Vorapaxar
C29H33FN2O4 (492.24242300000003)
PA(2:0/18:1(12Z)-O(9S,10R))
PA(2:0/18:1(12Z)-O(9S,10R)) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(2:0/18:1(12Z)-O(9S,10R)), in particular, consists of one chain of one acetyl at the C-1 position and one chain of 9,10-epoxy-octadecenoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).
PA(18:1(12Z)-O(9S,10R)/2:0)
PA(18:1(12Z)-O(9S,10R)/2:0) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(18:1(12Z)-O(9S,10R)/2:0), in particular, consists of one chain of one 9,10-epoxy-octadecenoyl at the C-1 position and one chain of acetyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).
PA(2:0/18:1(9Z)-O(12,13))
PA(2:0/18:1(9Z)-O(12,13)) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(2:0/18:1(9Z)-O(12,13)), in particular, consists of one chain of one acetyl at the C-1 position and one chain of 12,13-epoxy-octadecenoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).
PA(18:1(9Z)-O(12,13)/2:0)
PA(18:1(9Z)-O(12,13)/2:0) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(18:1(9Z)-O(12,13)/2:0), in particular, consists of one chain of one 12,13-epoxy-octadecenoyl at the C-1 position and one chain of acetyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).
leukotriene-D4
C25H36N2O6S (492.22939560000003)
Leukotriene-d4 is practically insoluble (in water) and a weakly acidic compound (based on its pKa). Leukotriene-d4 can be found in a number of food items such as prunus (cherry, plum), horned melon, wasabi, and grass pea, which makes leukotriene-d4 a potential biomarker for the consumption of these food products.
Kushenol B
Kushenol B is a member of flavanones. Kushenol B is a natural product found in Sophora and Sophora flavescens with data available.
Taxuspine W
Taxuspine W is a natural product found in Taxus wallichiana, Taxus baccata, and other organisms with data available.
Kadlongilactone B
A hexacyclic triterpenoid isolated from the leaves and stems of Kadsura longipedunculata and has been found to exhibit cytotoxicity aganist human tumour cells.
Macaflavanone G
A trihydroxyflavanone that is (2S)-flavanone substituted by hydroxy groups at positions 5, 7 and 4, a prenyl group at position 6 and a (2S)-2-methyl-2-(4-methylpent-3-en-1-yl)tetrahydro-2H-pyran ring fused across positions 2 and 3. Isolated from the leaves of Macaranga tanarius, it exhibits antineoplastic activity.
2,4,6,3-Tetrahydroxy-3-geranyl-6,6-dimethylpyrano[2,3:4,5]dihydrochalcone
Propolin G
(3E,7E)-2alpha,10beta,13alpha-triacetoxy-5alpha,20-dihydroxy-3,8-secotaxa-3,7,11-trien-9-one|(3E,7E)-2??,10??,13??-Triacetoxy-5??,20-dihydroxy-3,8-seco-taxa-3,7,11-trien-9-one
(-)-Nymphaeol C|(-)-Nymphaeol-C|5,7,3,4-tetrahydroxy-6-(3,3-dimethylallyl)-2-C-geranylflavanone|5,7,3,4-tetrahydroxy-6-(3,3-dimethylallyl)-2-geranylflavanone|Nymphaeol C|nymphaeol-C|propolin G
1alpha,3beta-dihydroxy-7beta,11beta,15beta-triacetoxy-ent-kaur-16-en-6-one|nervonin C
1alpha,3beta-dihydroxy-6alpha,7beta,11beta-triacetoxy-ent-kaur-16-en-15-one|nervonin B
durumolide H|rel-(1R,3S,4S,13R,14R,7E,11E)-3,13,18-triacetoxy-4-hydroxycembra-7,11,15(17)-trien-16,14-olide
(E)-1,3-dihydroxy-6,7-dimethoxy-2-(3-methylbut-2-enyl)-8-(3,7-dimethyl-2,6-octadienyl)xanthone|6-O-methylcowanin
3beta-hydroxy-8beta-<5-hydroxy-4-(2-hydroxy-3-methylvaleroyloxy)tigloyloxy>costunolide|3beta-hydroxy-8beta-[5-hydroxy-4-(2-hydroxy-3-methylvaleroyloxy)tigloyloxy]costunolide
Acetic acid 2,3-bis(3,4,5-trimethoxybenzyl)-4-hydroxybutyl ester
lespeflorin B4
A trihydroxyflavanone that is (2S)-flavanone substituted by hydroxy groups at positions 3, 5, 7 and 4 and prenyl groups at positions 6, 8 and 3. Isolated from the roots of Lespedeza floribunda, it acts as a melanin synthesis inhibitor.
2alpha,7beta,13alpha-triacetoxy-5alpha,9alpha-dihydroxy-2(3->20)abeotaxa-4(20),11-dien-10-one|2??,7??,13??-Triacetoxy-5??,9??-dihydroxy-2(3鈥樏傗垎20)abeotaxa-4(20),11-dien-10-one
2alpha,7beta,10beta-triacetoxy-5alpha,13alpha-dihydroxy-2(3->20)abeotaxa-4(20),11-dien-9-one
2alpha,9alpha,10beta-triacetoxy-11,12-epoxy-20-hydroxytaxa-4-en-13-one
Sanggenol P
(1alpha,11beta,15beta)-1,6,11-triacetyloxy-15-hydroxy-6,7-seco-ent-kaur-16-en-7,20-olide|isorubesin A
5,7,2,4-tetrahydroxyl-6,8,5-tri-(gamma,gamma-dimethylallyl)isoflavanone|6,8,5-tri-(gamma,gamma-dimethylallyl)dalbergioidin|ormosinol
(1S,4S,5S,6R,7R,8S,9S,10S)-1,15-diacetoxy-9-benzoyloxy-4,6,8-trihydroxy-dihydro-beta-agarofuran
Ala Phe Gln Gln
C22H32N6O7 (492.23323619999996)
Ala Gln Phe Gln
C22H32N6O7 (492.23323619999996)
Ala Gln Gln Phe
C22H32N6O7 (492.23323619999996)
Cys Asp Lys Lys
Cys Lys Asp Lys
Cys Lys Lys Asp
Cys Lys Arg Ser
Cys Lys Ser Arg
Cys Arg Lys Ser
Cys Arg Ser Lys
Cys Ser Lys Arg
Cys Ser Arg Lys
Asp Cys Lys Lys
Asp Lys Cys Lys
Asp Lys Lys Cys
Phe Ala Gln Gln
C22H32N6O7 (492.23323619999996)
Phe Gly Asn Arg
C21H32N8O6 (492.24446919999997)
Phe Gly Arg Asn
C21H32N8O6 (492.24446919999997)
Phe Met Pro Val
C24H36N4O5S (492.24062860000004)
Phe Met Val Pro
C24H36N4O5S (492.24062860000004)
Phe Asn Gly Arg
C21H32N8O6 (492.24446919999997)
Phe Asn Asn Val
C22H32N6O7 (492.23323619999996)
Phe Asn Arg Gly
C21H32N8O6 (492.24446919999997)
Phe Asn Val Asn
C22H32N6O7 (492.23323619999996)
Phe Pro Met Val
C24H36N4O5S (492.24062860000004)
Phe Pro Val Met
C24H36N4O5S (492.24062860000004)
Phe Gln Ala Gln
C22H32N6O7 (492.23323619999996)
Phe Gln Gln Ala
C22H32N6O7 (492.23323619999996)
Phe Arg Gly Asn
C21H32N8O6 (492.24446919999997)
Phe Arg Asn Gly
C21H32N8O6 (492.24446919999997)
Phe Val Met Pro
C24H36N4O5S (492.24062860000004)
Phe Val Asn Asn
C22H32N6O7 (492.23323619999996)
Phe Val Pro Met
C24H36N4O5S (492.24062860000004)
Gly Phe Asn Arg
C21H32N8O6 (492.24446919999997)
Gly Phe Arg Asn
C21H32N8O6 (492.24446919999997)
Gly Asn Phe Arg
C21H32N8O6 (492.24446919999997)
Gly Asn Arg Phe
C21H32N8O6 (492.24446919999997)
Gly Arg Phe Asn
C21H32N8O6 (492.24446919999997)
Gly Arg Asn Phe
C21H32N8O6 (492.24446919999997)
His His Ile Ser
C21H32N8O6 (492.24446919999997)
His His Leu Ser
C21H32N8O6 (492.24446919999997)
His His Ser Ile
C21H32N8O6 (492.24446919999997)
His His Ser Leu
C21H32N8O6 (492.24446919999997)
His His Thr Val
C21H32N8O6 (492.24446919999997)
His His Val Thr
C21H32N8O6 (492.24446919999997)
His Ile His Ser
C21H32N8O6 (492.24446919999997)
His Ile Ser His
C21H32N8O6 (492.24446919999997)
His Leu His Ser
C21H32N8O6 (492.24446919999997)
His Leu Ser His
C21H32N8O6 (492.24446919999997)
His Ser His Ile
C21H32N8O6 (492.24446919999997)
His Ser His Leu
C21H32N8O6 (492.24446919999997)
His Ser Ile His
C21H32N8O6 (492.24446919999997)
His Ser Leu His
C21H32N8O6 (492.24446919999997)
His Thr His Val
C21H32N8O6 (492.24446919999997)
His Thr Val His
C21H32N8O6 (492.24446919999997)
His Val His Thr
C21H32N8O6 (492.24446919999997)
His Val Thr His
C21H32N8O6 (492.24446919999997)
Ile His His Ser
C21H32N8O6 (492.24446919999997)
Ile His Ser His
C21H32N8O6 (492.24446919999997)
Ile Met Met Val
C21H40N4O5S2 (492.24399900000003)
Ile Met Val Met
C21H40N4O5S2 (492.24399900000003)
Ile Ser His His
C21H32N8O6 (492.24446919999997)
Ile Val Met Met
C21H40N4O5S2 (492.24399900000003)
Lys Cys Asp Lys
Lys Cys Lys Asp
Lys Cys Arg Ser
Lys Cys Ser Arg
Lys Asp Cys Lys
Lys Asp Lys Cys
Lys Lys Cys Asp
Lys Lys Asp Cys
Lys Met Asn Thr
Lys Met Gln Ser
Lys Met Ser Gln
Lys Met Thr Asn
Lys Asn Met Thr
Lys Asn Thr Met
Lys Gln Met Ser
Lys Gln Ser Met
Lys Arg Cys Ser
Lys Arg Ser Cys
Lys Ser Cys Arg
Lys Ser Met Gln
Lys Ser Gln Met
Lys Ser Arg Cys
Lys Thr Met Asn
Lys Thr Asn Met
Leu His His Ser
C21H32N8O6 (492.24446919999997)
Leu His Ser His
C21H32N8O6 (492.24446919999997)
Leu Met Met Val
C21H40N4O5S2 (492.24399900000003)
Leu Met Val Met
C21H40N4O5S2 (492.24399900000003)
Leu Ser His His
C21H32N8O6 (492.24446919999997)
Leu Val Met Met
C21H40N4O5S2 (492.24399900000003)
Met Phe Pro Val
C24H36N4O5S (492.24062860000004)
Met Phe Val Pro
C24H36N4O5S (492.24062860000004)
Met Ile Met Val
C21H40N4O5S2 (492.24399900000003)
Met Ile Val Met
C21H40N4O5S2 (492.24399900000003)
Met Lys Asn Thr
Met Lys Gln Ser
Met Lys Ser Gln
Met Lys Thr Asn
Met Leu Met Val
C21H40N4O5S2 (492.24399900000003)
Met Leu Val Met
C21H40N4O5S2 (492.24399900000003)
Met Met Ile Val
C21H40N4O5S2 (492.24399900000003)
Met Met Leu Val
C21H40N4O5S2 (492.24399900000003)
Met Met Val Ile
C21H40N4O5S2 (492.24399900000003)
Met Met Val Leu
C21H40N4O5S2 (492.24399900000003)
Met Asn Lys Thr
Met Asn Thr Lys
Met Pro Phe Val
C24H36N4O5S (492.24062860000004)
Met Pro Val Phe
C24H36N4O5S (492.24062860000004)
Met Gln Lys Ser
Met Gln Ser Lys
Met Ser Lys Gln
Met Ser Gln Lys
Met Thr Lys Asn
Met Thr Asn Lys
Met Val Phe Pro
C24H36N4O5S (492.24062860000004)
Met Val Ile Met
C21H40N4O5S2 (492.24399900000003)
Met Val Leu Met
C21H40N4O5S2 (492.24399900000003)
Met Val Met Ile
C21H40N4O5S2 (492.24399900000003)
Met Val Met Leu
C21H40N4O5S2 (492.24399900000003)
Met Val Pro Phe
C24H36N4O5S (492.24062860000004)
Asn Phe Gly Arg
C21H32N8O6 (492.24446919999997)
Asn Phe Asn Val
C22H32N6O7 (492.23323619999996)
Asn Phe Arg Gly
C21H32N8O6 (492.24446919999997)
Asn Phe Val Asn
C22H32N6O7 (492.23323619999996)
Asn Gly Phe Arg
C21H32N8O6 (492.24446919999997)
Asn Gly Arg Phe
C21H32N8O6 (492.24446919999997)
Asn Lys Met Thr
Asn Lys Thr Met
Asn Met Lys Thr
Asn Met Thr Lys
Asn Asn Phe Val
C22H32N6O7 (492.23323619999996)
Asn Asn Val Phe
C22H32N6O7 (492.23323619999996)
Asn Arg Phe Gly
C21H32N8O6 (492.24446919999997)
Asn Arg Gly Phe
C21H32N8O6 (492.24446919999997)
Asn Thr Lys Met
Asn Thr Met Lys
Asn Val Phe Asn
C22H32N6O7 (492.23323619999996)
Asn Val Asn Phe
C22H32N6O7 (492.23323619999996)
Pro Phe Met Val
C24H36N4O5S (492.24062860000004)
Pro Phe Val Met
C24H36N4O5S (492.24062860000004)
Pro Met Phe Val
C24H36N4O5S (492.24062860000004)
Pro Met Val Phe
C24H36N4O5S (492.24062860000004)
Pro Val Phe Met
C24H36N4O5S (492.24062860000004)
Pro Val Met Phe
C24H36N4O5S (492.24062860000004)
Gln Ala Phe Gln
C22H32N6O7 (492.23323619999996)
Gln Ala Gln Phe
C22H32N6O7 (492.23323619999996)
Gln Phe Ala Gln
C22H32N6O7 (492.23323619999996)
Gln Phe Gln Ala
C22H32N6O7 (492.23323619999996)
Gln Lys Met Ser
Gln Lys Ser Met
Gln Met Lys Ser
Gln Met Ser Lys
Gln Gln Ala Phe
C22H32N6O7 (492.23323619999996)
Gln Gln Phe Ala
C22H32N6O7 (492.23323619999996)
Gln Ser Lys Met
Gln Ser Met Lys
Arg Cys Lys Ser
Arg Cys Ser Lys
Arg Phe Gly Asn
C21H32N8O6 (492.24446919999997)
Arg Phe Asn Gly
C21H32N8O6 (492.24446919999997)
Arg Gly Phe Asn
C21H32N8O6 (492.24446919999997)
Arg Gly Asn Phe
C21H32N8O6 (492.24446919999997)
Arg Lys Cys Ser
Arg Lys Ser Cys
Arg Asn Phe Gly
C21H32N8O6 (492.24446919999997)
Arg Asn Gly Phe
C21H32N8O6 (492.24446919999997)
Arg Ser Cys Lys
Arg Ser Lys Cys
Ser Cys Lys Arg
Ser Cys Arg Lys
Ser His His Ile
C21H32N8O6 (492.24446919999997)
Ser His His Leu
C21H32N8O6 (492.24446919999997)
Ser His Ile His
C21H32N8O6 (492.24446919999997)
Ser His Leu His
C21H32N8O6 (492.24446919999997)
Ser Ile His His
C21H32N8O6 (492.24446919999997)
Ser Lys Cys Arg
Ser Lys Met Gln
Ser Lys Gln Met
Ser Lys Arg Cys
Ser Leu His His
C21H32N8O6 (492.24446919999997)
Ser Met Lys Gln
Ser Met Gln Lys
Ser Gln Lys Met
Ser Gln Met Lys
Ser Arg Cys Lys
Ser Arg Lys Cys
Thr His His Val
C21H32N8O6 (492.24446919999997)
Thr His Val His
C21H32N8O6 (492.24446919999997)
Thr Lys Met Asn
Thr Lys Asn Met
Thr Met Lys Asn
Thr Met Asn Lys
Thr Asn Lys Met
Thr Asn Met Lys
Thr Val His His
C21H32N8O6 (492.24446919999997)
Val Phe Met Pro
C24H36N4O5S (492.24062860000004)
Val Phe Asn Asn
C22H32N6O7 (492.23323619999996)
Val Phe Pro Met
C24H36N4O5S (492.24062860000004)
Val His His Thr
C21H32N8O6 (492.24446919999997)
Val His Thr His
C21H32N8O6 (492.24446919999997)
Val Ile Met Met
C21H40N4O5S2 (492.24399900000003)
Val Leu Met Met
C21H40N4O5S2 (492.24399900000003)
Val Met Phe Pro
C24H36N4O5S (492.24062860000004)
Val Met Ile Met
C21H40N4O5S2 (492.24399900000003)
Val Met Leu Met
C21H40N4O5S2 (492.24399900000003)
Val Met Met Ile
C21H40N4O5S2 (492.24399900000003)
Val Met Met Leu
C21H40N4O5S2 (492.24399900000003)
Val Met Pro Phe
C24H36N4O5S (492.24062860000004)
Val Asn Phe Asn
C22H32N6O7 (492.23323619999996)
Val Asn Asn Phe
C22H32N6O7 (492.23323619999996)
Val Pro Phe Met
C24H36N4O5S (492.24062860000004)
Val Pro Met Phe
C24H36N4O5S (492.24062860000004)
Val Thr His His
C21H32N8O6 (492.24446919999997)
Vorapaxar
C29H33FN2O4 (492.24242300000003)
B - Blood and blood forming organs > B01 - Antithrombotic agents > B01A - Antithrombotic agents > B01AC - Platelet aggregation inhibitors excl. heparin C78275 - Agent Affecting Blood or Body Fluid > C1327 - Antiplatelet Agent D006401 - Hematologic Agents > D010975 - Platelet Aggregation Inhibitors C78274 - Agent Affecting Cardiovascular System COVID info from Guide to PHARMACOLOGY Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS
ethyl ((1R,3aR,4aR,6R,8aR,9S,9aS)-9-((E)-2-(5-(3-fluorophenyl)pyridin-2-yl)vinyl)-1-methyl-3-oxododecahydronaphtho[2,3-c]furan-6-yl)carbamate
C29H33FN2O4 (492.24242300000003)
5,6-Epoxyretinoyl glucuronide
D020011 - Protective Agents > D000975 - Antioxidants > D002338 - Carotenoids
ethyl N-[9-[(E)-2-[5-(3-fluorophenyl)pyridin-2-yl]ethenyl]-1-methyl-3-oxo-3a,4,4a,5,6,7,8,8a,9,9a-decahydro-1H-benzo[f][2]benzofuran-6-yl]carbamate
C29H33FN2O4 (492.24242300000003)
[(2R)-1-acetyloxy-3-phosphonooxypropan-2-yl] (Z)-11-(3-pentyloxiran-2-yl)undec-9-enoate
[(2R)-2-acetyloxy-3-phosphonooxypropyl] (Z)-11-(3-pentyloxiran-2-yl)undec-9-enoate
Nymphaeol C
A tetrahydroxyflavanone that is (2S)-flavanone substituted by hydroxy group at positions 5, 7, 3 and 4, a geranyl group at position 2 and a prenyl group at position 6. Isolated from Macaranga tanarius and propolis collected in Okinawa, it exhibits radical scavenging activity.
schizolaenone B
A tetrahydroxyflavanone that is (2S)-flavanone substituted by hydroxy groups at positions 5, 7, 4 and 5, a geranyl group at position 3 and a prenyl group at position 6. Isolated from Schizolaena hystrix, it exhibits cytotoxicity against ovarian cancer cell line.
3-[1-azepanyl-[1-[(4-fluorophenyl)methyl]-5-tetrazolyl]methyl]-6,7-dimethoxy-1H-quinolin-2-one
C26H29FN6O3 (492.22850559999995)
(1R,2S,4aS,5R,6S,8R,8aS)-8a-[(acetyloxy)methyl]-5,6-dimethyl-5-[(2R,3aR,6aR)-2,3,3a,6a-tetrahydrofuro[2,3-b]furan-2-yl]octahydro-2H-spiro[naphthalene-1,2-oxirane]-2,8-diyl diacetate
3-[(1-tert-butyl-5-tetrazolyl)-[2-furanylmethyl(2-oxolanylmethyl)amino]methyl]-6-methoxy-1H-quinolin-2-one
(2S,3S,3aR,9bR)-N1-cyclopentyl-N2-(cyclopropylmethyl)-3-(hydroxymethyl)-6-oxo-7-(5-pyrimidinyl)-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizine-1,2-dicarboxamide
(2R,3R,3aS,9bS)-N1-cyclopentyl-N2-(cyclopropylmethyl)-3-(hydroxymethyl)-6-oxo-7-(5-pyrimidinyl)-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizine-1,2-dicarboxamide
(1S)-1-(hydroxymethyl)-7-methoxy-1-[oxo(2-pyrazinyl)methyl]-N-propan-2-yl-2-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,4-piperidine]carboxamide
1-[(1S)-1-(hydroxymethyl)-7-methoxy-9-methyl-1-[oxo(2-pyridinyl)methyl]-2-spiro[1,3-dihydropyrido[3,4-b]indole-4,4-piperidine]yl]-2-methoxyethanone
(1R)-1-(hydroxymethyl)-7-methoxy-1-[oxo(2-pyrazinyl)methyl]-N-propan-2-yl-2-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,4-piperidine]carboxamide
1-[(1R)-1-(hydroxymethyl)-7-methoxy-9-methyl-1-[oxo(2-pyridinyl)methyl]-2-spiro[1,3-dihydropyrido[3,4-b]indole-4,4-piperidine]yl]-2-methoxyethanone
4-(beta-D-glucopyranuronosyloxy)retinoic acid
A hydroxyretinoic glucuronide that is all-trans-4-hydroxyretinoic acid attached to a beta-D-glucuronic acid residue via a glycosidic linkage.
1-O-all-trans-4-hydroxyretinoyl-beta-glucuronic acid
A hydroxyretinoic glucuronide obtained by the glycosylation of the carboxy group of all-trans-4-hydroxyretinoic acid with beta-glucuronic acid.
(2R,3R,3aS,9bS)-1-N-cyclopentyl-3-(hydroxymethyl)-6-oxo-7-[(E)-prop-1-enyl]-2-N-(pyrimidin-4-ylmethyl)-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizine-1,2-dicarboxamide
methyl 6-{[4-deoxy-4-formamido-alpha-D-rhamnopyranosyl-(1->3)-4-deoxy-4-formamido-alpha-D-rhamnopyranosyl]oxy}hexanoate
(2S,3S,3aR,9bR)-1-N-cyclopentyl-3-(hydroxymethyl)-6-oxo-7-[(E)-prop-1-enyl]-2-N-(pyrimidin-4-ylmethyl)-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizine-1,2-dicarboxamide
1-O-(5,6-epoxyretinoyl)-beta-D-glucuronic acid
A retinoid that is 5,6-epoxyretinoic acid in which the carboxy proton has been replaced by a beta-D-glucuronyl residue.
3,12-bis(acetyloxy)-10,14-dihydroxy-7,11,16,16-tetramethyl-9-oxotricyclo[9.3.1.1⁴,⁸]hexadeca-1,7-dien-6-yl acetate
(1r,2s)-1-[(1r,4as,8s,9r,11ar)-1-(acetyloxy)-8,9-dihydroxy-7-methyl-11-methylidene-1h,4ah,5h,8h,9h,10h,11ah-cyclonona[c]pyran-4-yl]-1-(acetyloxy)-4-methylpent-3-en-2-yl acetate
4,8,11b-trimethyl-4-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)-1h,2h,3h,4ah,5h,6h,10ah,11h-phenanthro[3,2-b]furan-7,9-dione
(1s,2r,3s,4r,7s,8z,12r,13s,14s)-12,14-bis(acetyloxy)-3-hydroxy-4,9,13,17-tetramethyl-5-oxo-6-oxatricyclo[11.4.0.0³,⁷]heptadeca-8,16-dien-2-yl acetate
(1r,2s,4ar,5r,6s,7r,8r,8ar)-2,7-bis(acetyloxy)-5-[2-(furan-3-yl)ethyl]-8-hydroxy-5,6-dimethyl-hexahydro-2h-spiro[naphthalene-1,2'-oxiran]-8a-ylmethyl acetate
5',9,9,14,18-pentamethyl-3'h-8,20,24-trioxaspiro[hexacyclo[19.2.1.0²,¹³.0⁴,¹⁰.0¹⁴,²².0¹⁷,²²]tetracosane-19,2'-pyran]-2(13),3,5-triene-6',7-dione
(2r,3s)-4-hydroxy-2,3-bis[(3,4,5-trimethoxyphenyl)methyl]butyl acetate
3,8,9-trihydroxy-4-[4-hydroxy-3-(hydroxymethyl)but-2-en-1-yl]-6-methyl-4,7-bis(3-methylbut-2-en-1-yl)anthracen-1-one
(1s,2r,3s,4r,7s,8z,12r,13s,14s)-12,14-bis(acetyloxy)-3-hydroxy-4,9,13-trimethyl-17-methylidene-5-oxo-6-oxatricyclo[11.4.0.0³,⁷]heptadec-8-en-2-yl acetate
(1s,10r,14s,17r,18s,19s,21r,22s)-5',9,9,14,18-pentamethyl-3'h-8,20,24-trioxaspiro[hexacyclo[19.2.1.0²,¹³.0⁴,¹⁰.0¹⁴,²².0¹⁷,²²]tetracosane-19,2'-pyran]-2(13),3,5-triene-6',7-dione
2,11-bis(acetyloxy)-6,8-dihydroxy-5,5,9-trimethyl-14-methylidene-3-oxotetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecan-15-yl acetate
(1e,3s,4r,6s,9r,11s,12s,14s)-3,12-bis(acetyloxy)-9,14-dihydroxy-7,11,16,16-tetramethyl-10-oxotricyclo[9.3.1.1⁴,⁸]hexadeca-1,7-dien-6-yl acetate
(4r,4as,10ar,11br)-4,8,11b-trimethyl-4-({[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)-1h,2h,3h,4ah,5h,6h,10ah,11h-phenanthro[3,2-b]furan-7,9-dione
2-[2-(3,7-dimethylocta-2,6-dien-1-yl)-3,4-dihydroxyphenyl]-5,7-dihydroxy-6-(3-methylbut-2-en-1-yl)-2,3-dihydro-1-benzopyran-4-one
5-(3-chloro-5-formyl-2,6-dihydroxy-4-methylphenyl)-3-methyl-1-(1,2,6-trimethyl-3-oxocyclohexyl)pent-3-en-2-yl butanoate
(2s)-2-[5-(3,7-dimethylocta-2,6-dien-1-yl)-2,4-dihydroxyphenyl]-5,7-dihydroxy-8-(3-methylbut-2-en-1-yl)-2,3-dihydro-1-benzopyran-4-one
(1s,1'r,2s,3's,5s,6's,9s,10's,11'r,12r,14s)-2-hydroxy-2,3',11,12'-tetramethyl-6-methylidene-2',8,9'-trioxaspiro[tetracyclo[10.2.1.0¹,¹⁰.0⁵,⁹]pentadecane-14,7'-tetracyclo[9.3.0.0¹,³.0⁶,¹⁰]tetradecane]-10,12'-diene-7,8'-dione
(1r,2r,3r,4s,6r,7s,9s,10s,11s,13s)-6,7-bis(acetyloxy)-3,11-dihydroxy-5,5,9-trimethyl-14-methylidene-15-oxotetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecan-2-yl acetate
(1r,2r,3r,4s,6r,7s,9s,10s,11s,13s)-2,6-bis(acetyloxy)-3,7-dihydroxy-5,5,9-trimethyl-14-methylidene-15-oxotetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecan-11-yl acetate
(1r,2s,3e,5s,7e,10r,13s)-2,10-bis(acetyloxy)-5-hydroxy-4-(hydroxymethyl)-8,12,15,15-tetramethyl-9-oxobicyclo[9.3.1]pentadeca-3,7,11-trien-13-yl acetate
(1'r,2s,2'r,3'r,5's,8'r,9'r,10'r)-9',10'-bis(acetyloxy)-5'-hydroxy-8',12',15',15'-tetramethyl-13'-oxospiro[oxirane-2,4'-tricyclo[9.3.1.0³,⁸]pentadecan]-11'-en-2'-yl acetate
(1r,2s,3r,4r,7s,9r,10r,11r,14s)-2,3-bis(acetyloxy)-7-hydroxy-4,14,16,16-tetramethyl-8-methylidene-13-oxo-15-oxatetracyclo[9.4.1.0¹,¹⁴.0⁴,⁹]hexadecan-10-yl acetate
2,8-bis(acetyloxy)-6,15-dihydroxy-5,5,9-trimethyl-14-methylidene-3-oxotetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecan-11-yl acetate
(2s)-5,7-dihydroxy-2-[(2r)-8-hydroxy-2-methyl-2-(4-methylpent-3-en-1-yl)-3,4-dihydro-1-benzopyran-6-yl]-6-(3-methylbut-2-en-1-yl)-2,3-dihydro-1-benzopyran-4-one
(1r,2s,3r,5s,7r,8s,9s,10s,11r,15s)-3,15-bis(acetyloxy)-9,10-dihydroxy-12,12-dimethyl-6-methylidene-17-oxapentacyclo[7.6.2.1⁵,⁸.0¹,¹¹.0²,⁸]octadecan-7-yl acetate
2,7-bis(acetyloxy)-6,11-dihydroxy-5,5,9-trimethyl-14-methylidene-15-oxotetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecan-3-yl acetate
(2r,4s,5s,7s,8e,10s,11r,13s)-2,10-bis(acetyloxy)-7,13-dihydroxy-4,14,15,15-tetramethyl-3-oxotricyclo[9.3.1.1⁴,⁸]hexadeca-1(14),8-dien-5-yl acetate
14-deoxo-14-O- acetylorthosiphol Y
{"Ingredient_id": "HBIN001404","Ingredient_name": "14-deoxo-14-O- acetylorthosiphol Y","Alias": "14-deoxo-14-o-acetylorthosiphol y","Ingredient_formula": "C26H36O9","Ingredient_Smile": "CC(=O)OC1CC2C(C(=O)C(=CC2(C3C1(C(C(CC3O)(C)C=C)OC(=O)C)O)C)OC(=O)C)(C)C","Ingredient_weight": "492.6 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "37493;5136","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "21578028","DrugBank_id": "NA"}
1-hydroxytaxinine a
{"Ingredient_id": "HBIN002663","Ingredient_name": "1-hydroxytaxinine a","Alias": "NA","Ingredient_formula": "C26H36O9","Ingredient_Smile": "CC1=C2C(C(C3(CCC(C(=C)C3C(C(C2(C)C)(CC1=O)O)OC(=O)C)O)C)OC(=O)C)OC(=O)C","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "SMIT15918","TCMID_id": "10738","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
2α,7β,13α-triacetoxy-5α,9α-dihydroxy-2(3→20)abeotaxa-4(20),11-dien-10-one
{"Ingredient_id": "HBIN005252","Ingredient_name": "2\u03b1,7\u03b2,13\u03b1-triacetoxy-5\u03b1,9\u03b1-dihydroxy-2(3\u219220)abeotaxa-4(20),11-dien-10-one","Alias": "NA","Ingredient_formula": "C26H36O9","Ingredient_Smile": "CC(=O)OC1CC2CC3(C1C4(C(CC(C(C4C(=O)C3O)(C)C)O)OC(=O)C)C)C(C2=C)OC(=O)C","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "21499","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
2-deacetyltaxine b
{"Ingredient_id": "HBIN005509","Ingredient_name": "2-deacetyltaxine b","Alias": "NA","Ingredient_formula": "C26H36O9","Ingredient_Smile": "CC1=C2C(C(=O)C3(CC(=CC(C(C2(C)C)CC1OC(=O)C)O)C(CC3OC(=O)C)O)C)OC(=O)C","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "4780","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
2-deactyltaxine b
{"Ingredient_id": "HBIN005510","Ingredient_name": "2-deactyltaxine b","Alias": "NA","Ingredient_formula": "C26H36O9","Ingredient_Smile": "CC1=C2C(C(=O)C3(CC(=CC(C(C2(C)C)CC1OC(=O)C)O)C(CC3OC(=O)C)O)C)OC(=O)C","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "30479","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
(3 e,7 e)-2α,10β,13α-triacetoxy-5α,20-dihydrox-y-3,8-seco-taxa-3,7,11-trien-9-one
{"Ingredient_id": "HBIN008454","Ingredient_name": "(3 e,7 e)-2\u03b1,10\u03b2,13\u03b1-triacetoxy-5\u03b1,20-dihydrox-y-3,8-seco-taxa-3,7,11-trien-9-one","Alias": "NA","Ingredient_formula": "C26H36O9","Ingredient_Smile": "CC(=O)OC1CC2CC3(C1C4(C(CC(C(C4C(=O)C3O)(C)C)O)OC(=O)C)C)C(C2=C)OC(=O)C","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "21500","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
(3E,7E)-2alpha,10beta,13alpha-Triacetoxy-5alpha,20-dihydroxy-3,8-seco-taxa-3,7,11-trien-9-one
{"Ingredient_id": "HBIN008455","Ingredient_name": "(3E,7E)-2alpha,10beta,13alpha-Triacetoxy-5alpha,20-dihydroxy-3,8-seco-taxa-3,7,11-trien-9-one","Alias": "[(1R,2S,3E,5S,7E,10R,13S)-2,10-diacetyloxy-5-hydroxy-4-(hydroxymethyl)-8,12,15,15-tetramethyl-9-oxo-13-bicyclo[9.3.1]pentadeca-3,7,11-trienyl] acetate; acetic acid [(1R,2S,3E,5S,7E,10R,13S)-2,10-diacetoxy-5-hydroxy-9-keto-8,12,15,15-tetramethyl-4-methylol-13-bicyclo[9.3.1]pentadeca-3,7,11-trienyl] ester; (3e,7e)-2alpha,10beta,13alpha-triacetoxy-5alpha,20-dihydroxy-3,8-seco-taxa-3,7,11-trien-9-one; [(1R,2S,3E,5S,7E,10R,13S)-2,10-diacetoxy-5-hydroxy-4-(hydroxymethyl)-8,12,15,15-tetramethyl-9-oxo-13-bicyclo[9.3.1]pentadeca-3,7,11-trienyl] acetate; acetic acid [(1R,2S,3E,5S,7E,10R,13S)-2,10-diacetoxy-5-hydroxy-4-(hydroxymethyl)-8,12,15,15-tetramethyl-9-oxo-13-bicyclo[9.3.1]pentadeca-3,7,11-trienyl] ester; [(1R,2S,3E,5S,7E,10R,13S)-2,10-diacetyloxy-5-hydroxy-4-(hydroxymethyl)-8,12,15,15-tetramethyl-9-oxo-13-bicyclo[9.3.1]pentadeca-3,7,11-trienyl] ethanoate","Ingredient_formula": "C26H36O9","Ingredient_Smile": "CC1=CCC(C(=CC(C2CC(C(=C(C2(C)C)C(C1=O)OC(=O)C)C)OC(=O)C)OC(=O)C)CO)O","Ingredient_weight": "492.6 g/mol","OB_score": "7.933338771","CAS_id": "NA","SymMap_id": "SMIT01016","TCMID_id": "32087","TCMSP_id": "MOL003237","TCM_ID_id": "NA","PubChem_id": "6326196","DrugBank_id": "NA"}
adenanthin j
{"Ingredient_id": "HBIN014681","Ingredient_name": "adenanthin j","Alias": "NA","Ingredient_formula": "C26H36O9","Ingredient_Smile": "CC(=O)OC1CC2CC3(C1C4(C(CC(C(C4C(=O)C3OC(=O)C)(C)C)O)OC(=O)C)C)C(C2=C)O","Ingredient_weight": "492.6 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "614","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "11081505","DrugBank_id": "NA"}
adenanthin k
{"Ingredient_id": "HBIN014682","Ingredient_name": "adenanthin k","Alias": "NA","Ingredient_formula": "C26H36O9","Ingredient_Smile": "CC(=O)OC1CC2CC3(C1C4(C(CC(C(C4C(=O)C3O)(C)C)O)OC(=O)C)C)C(C2=C)OC(=O)C","Ingredient_weight": "492.6 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "615","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "11081506","DrugBank_id": "NA"}
(1r,2r,3r,4s,6r,7s,9r,10s,11s,13s)-6,7-bis(acetyloxy)-3,11-dihydroxy-5,5,9-trimethyl-14-methylidene-15-oxotetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecan-2-yl acetate
(1r,3r,4r,5r,7s,10r,11r,12r,14s)-11,12-bis(acetyloxy)-1,7-dihydroxy-10,14,17-trimethyl-6-methylidene-16-oxatetracyclo[11.3.1.0³,¹⁴.0⁵,¹⁰]heptadec-13(17)-en-4-yl acetate
3,7-bis(acetyloxy)-2,6-dihydroxy-5,5,9-trimethyl-14-methylidene-15-oxotetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecan-11-yl acetate
2,6-bis(acetyloxy)-3,7-dihydroxy-5,5,9-trimethyl-14-methylidene-15-oxotetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecan-11-yl acetate
methyl (2s)-2-[(3as,3bs,4s,5as,9as,9bs,11as)-1,4-dihydroxy-3b,6,6,9a,11a-pentamethyl-11-methylidene-3,5,7-trioxo-hexahydro-3ah-phenanthro[1,2-c]furan-1-yl]-2-hydroxypropanoate
(1s,2r,4r,4as,4br,8ar,10r,10ar)-6,10-bis(acetyloxy)-2-ethenyl-4,10a-dihydroxy-2,4b,8,8-tetramethyl-7-oxo-3,4,4a,8a,9,10-hexahydro-1h-phenanthren-1-yl acetate
(1r,2s,3r,4r,9r,10r,11r,14s)-2,10-bis(acetyloxy)-8-(hydroxymethyl)-4,14,16,16-tetramethyl-13-oxo-15-oxatetracyclo[9.4.1.0¹,¹⁴.0⁴,⁹]hexadec-7-en-3-yl acetate
(1s,3s,4r,6r,7s,10s,11s,13s)-6,7-bis(acetyloxy)-3,8-dihydroxy-5,5,9-trimethyl-14-methylidene-15-oxotetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecan-11-yl acetate
(1s,2s,4as,5r,6s,8r,8as)-5-[(2r,3ar,6ar)-2h,3h,3ah,6ah-furo[2,3-b]furan-2-yl]-2,8-bis(acetyloxy)-5,6-dimethyl-hexahydro-2h-spiro[naphthalene-1,2'-oxiran]-8a-ylmethyl acetate
2,14-bis(acetyloxy)-3-hydroxy-4,9,13-trimethyl-17-methylidene-5-oxo-6-oxatricyclo[11.4.0.0³,⁷]heptadec-8-en-12-yl acetate
(1s,2s,3s,4r,7s,8z,12s,13s,14s)-2,14-bis(acetyloxy)-3-hydroxy-4,9,13-trimethyl-17-methylidene-5-oxo-6-oxatricyclo[11.4.0.0³,⁷]heptadec-8-en-12-yl acetate
(1r,2r,3r,4s,6r,7s,9s,10s,11s,13s)-2,7-bis(acetyloxy)-6,11-dihydroxy-5,5,9-trimethyl-14-methylidene-15-oxotetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecan-3-yl acetate
(1r,2r,3r,4s,6r,7s,9r,10s,11s,13s)-2,7-bis(acetyloxy)-6,11-dihydroxy-5,5,9-trimethyl-14-methylidene-15-oxotetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecan-3-yl acetate
(1r,2r,3r,4s,6r,7s,9r,10s,11s,13s)-2,6-bis(acetyloxy)-7,11-dihydroxy-5,5,9-trimethyl-14-methylidene-15-oxotetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecan-3-yl acetate
2-[(1r,4ar,5r,6r,8s,8ar)-5,8a-bis[(acetyloxy)methyl]-8-hydroxy-6-methyl-hexahydro-2h-spiro[naphthalene-1,2'-oxiran]-5-yl]-1-(furan-3-yl)ethyl acetate
(1s)-1-[(1s,2r,3s,4r,4ar,8as)-3,4-bis(acetyloxy)-2-hydroxy-1,2,4a,5-tetramethyl-4,7,8,8a-tetrahydro-3h-naphthalen-1-yl]-2-(5-oxo-2h-furan-3-yl)ethyl acetate
(1r,2r,4ar,5s,6r,8s,8ar)-5-[(2s,3as,6as)-2h,3h,3ah,6ah-furo[2,3-b]furan-2-yl]-2,8-bis(acetyloxy)-5,6-dimethyl-hexahydro-2h-spiro[naphthalene-1,2'-oxiran]-8a-ylmethyl acetate
5-{2h,3h,3ah,6ah-furo[2,3-b]furan-2-yl}-3,8-bis(acetyloxy)-5,6-dimethyl-hexahydro-2h-spiro[naphthalene-1,2'-oxiran]-8a-ylmethyl acetate
(1r,2r,3r,4s,6r,7s,9s,10s,11s,13s)-3,7-bis(acetyloxy)-2,6-dihydroxy-5,5,9-trimethyl-14-methylidene-15-oxotetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecan-11-yl acetate
(1r,2r,3r,4r,6s,8s,9r,10s,11s,13s)-2,8-bis(acetyloxy)-3,6-dihydroxy-5,5,9-trimethyl-14-methylidene-15-oxotetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecan-11-yl acetate
(1s)-2-[(1r,4ar,5r,6r,8s,8ar)-5,8a-bis[(acetyloxy)methyl]-8-hydroxy-6-methyl-hexahydro-2h-spiro[naphthalene-1,2'-oxiran]-5-yl]-1-(furan-3-yl)ethyl acetate
1-(acetyloxy)-1-[1-(acetyloxy)-8,9-dihydroxy-7-methyl-11-methylidene-1h,4ah,5h,8h,9h,10h,11ah-cyclonona[c]pyran-4-yl]-4-methylpent-3-en-2-yl acetate
2,8-bis(acetyloxy)-3,6-dihydroxy-5,5,9-trimethyl-14-methylidene-15-oxotetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecan-11-yl acetate
8,11-bis(acetyloxy)-2,6-dihydroxy-5,5,9-trimethyl-14-methylidene-3-oxotetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecan-15-yl acetate
9,12-bis(acetyloxy)-3,14-dihydroxy-7,11,16,16-tetramethyl-10-oxotricyclo[9.3.1.1⁴,⁸]hexadeca-1,7-dien-6-yl acetate
1-(acetyloxy)-1-[1-(acetyloxy)-8,9-dihydroxy-7,11-dimethylidene-1h,4ah,5h,6h,8h,9h,10h,11ah-cyclonona[c]pyran-4-yl]-4-methylpent-3-en-2-yl acetate
6,7-bis(acetyloxy)-3,8-dihydroxy-5,5,9-trimethyl-14-methylidene-15-oxotetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecan-11-yl acetate
(1e,3s,4r,6s,10r,11r,12s,14s)-3,12-bis(acetyloxy)-10,14-dihydroxy-7,11,16,16-tetramethyl-9-oxotricyclo[9.3.1.1⁴,⁸]hexadeca-1,7-dien-6-yl acetate
(5s,6ar,7s,8r,10as)-7-[2-(furan-3-yl)ethyl]-7,8-dimethyl-5-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,5h,6h,6ah,8h,9h,10h-naphtho[4,4a-c]furan-3-one
2-{5,8a-bis[(acetyloxy)methyl]-8-hydroxy-6-methyl-hexahydro-2h-spiro[naphthalene-1,2'-oxiran]-5-yl}-1-(furan-3-yl)ethyl acetate
(1r,2s,4ar,5s,6s,7r,8r,8ar)-2,7-bis(acetyloxy)-5-[2-(furan-3-yl)ethyl]-8-hydroxy-5,6-dimethyl-hexahydro-2h-spiro[naphthalene-1,2'-oxiran]-8a-ylmethyl acetate
(1'r,2r,2's,4'r,5's,6'r,8'r,9's,11'r)-5'-[(2s,3as,6as)-2h,3h,3ah,6ah-furo[2,3-b]furan-2-yl]-2'-(acetyloxy)-9'-hydroxy-4',5'-dimethyl-12'-oxaspiro[oxirane-2,10'-tricyclo[6.2.2.0¹,⁶]dodecan]-11'-yl 2-methylpropanoate
2-(acetyloxy)-3,17-dihydroxy-4,9,13,17-tetramethyl-5,16-dioxo-6-oxatricyclo[11.4.0.0³,⁷]heptadeca-8,14-dien-12-yl butanoate
1,2-bis(acetyloxy)-4a,7-dihydroxy-4,4,7,11b-tetramethyl-1h,2h,3h,5h,6h,6ah,11h,11ah-phenanthro[3,2-b]furan-3-yl acetate
(1r,2r,4ar,5s,6r,8s,8ar)-5-[(3as,6as)-2h,3h,3ah,6ah-furo[2,3-b]furan-2-yl]-2,8-bis(acetyloxy)-5,6-dimethyl-hexahydro-2h-spiro[naphthalene-1,2'-oxiran]-8a-ylmethyl acetate
(1's,2r,2's,4'r,5's,6'r,8'r,9's,11'r)-5'-[(2s,3as,6ar)-2h,3h,3ah,6ah-furo[2,3-b]furan-2-yl]-2'-(acetyloxy)-9'-hydroxy-4',5'-dimethyl-12'-oxaspiro[oxirane-2,10'-tricyclo[6.2.2.0¹,⁶]dodecan]-11'-yl 2-methylpropanoate
3,12-bis(acetyloxy)-9,14-dihydroxy-7,11,16,16-tetramethyl-10-oxotricyclo[9.3.1.1⁴,⁸]hexadeca-1,7-dien-6-yl acetate
(1s,2r)-1-[(1s,4ar,8r,9s,11as)-1-(acetyloxy)-8,9-dihydroxy-7-methyl-11-methylidene-1h,4ah,5h,8h,9h,10h,11ah-cyclonona[c]pyran-4-yl]-1-(acetyloxy)-4-methylpent-3-en-2-yl acetate
(1s,2r,3r,4r,7s,8z,12r,13s,14s)-12,14-bis(acetyloxy)-3-hydroxy-4,9,13-trimethyl-17-methylidene-5-oxo-6-oxatricyclo[11.4.0.0³,⁷]heptadec-8-en-2-yl acetate
(1r,2r,3r,4s,6r,7s,9r,10s,11s,13s)-2,6-bis(acetyloxy)-3,7-dihydroxy-5,5,9-trimethyl-14-methylidene-15-oxotetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecan-11-yl acetate
[5,15-bis(acetyloxy)-6-hydroxy-10,14-dimethyl-3-methylidene-2-oxo-3ah,4h,5h,7h,8h,11h,12h,15h,15ah-cyclotetradeca[b]furan-6-yl]methyl acetate
2,10-bis(acetyloxy)-5-hydroxy-4-(hydroxymethyl)-8,12,15,15-tetramethyl-9-oxobicyclo[9.3.1]pentadeca-3,7,11-trien-13-yl acetate
(2e)-4-{[(3ar,4r,9r,11ar)-9-hydroxy-6,10-dimethyl-3-methylidene-2-oxo-3ah,4h,5h,8h,9h,11ah-cyclodeca[b]furan-4-yl]oxy}-3-(hydroxymethyl)-4-oxobut-2-en-1-yl (2r,3s)-2-hydroxy-3-methylpentanoate
(2r,2's,4'r,6'r,9'r)-5'-[(2s,3ar)-2h,3h,3ah,6ah-furo[2,3-b]furan-2-yl]-2'-(acetyloxy)-9'-hydroxy-4',5'-dimethyl-12'-oxaspiro[oxirane-2,10'-tricyclo[6.2.2.0¹,⁶]dodecan]-11'-yl 2-methylpropanoate
(1s,4ar,5s,6r,6as,7r,11as,11bs)-1,6-bis(acetyloxy)-4a,7-dihydroxy-4,4,7,11b-tetramethyl-1h,2h,3h,5h,6h,6ah,11h,11ah-phenanthro[3,2-b]furan-5-yl acetate
(1s,2r)-1-[(1s,4ar,8r,9s,11as)-1-(acetyloxy)-8,9-dihydroxy-7,11-dimethylidene-1h,4ah,5h,6h,8h,9h,10h,11ah-cyclonona[c]pyran-4-yl]-1-(acetyloxy)-4-methylpent-3-en-2-yl acetate
4,12-bis(acetyloxy)-1,7-dihydroxy-10,14,17-trimethyl-6-methylidene-16-oxatetracyclo[11.3.1.0³,¹⁴.0⁵,¹⁰]heptadec-13(17)-en-11-yl acetate
(1's,2r,2's,4'r,5's,6'r,9's,11'r)-5'-[(2s,3as,6ar)-2h,3h,3ah,6ah-furo[2,3-b]furan-2-yl]-2'-(acetyloxy)-9'-hydroxy-4',5'-dimethyl-12'-oxaspiro[oxirane-2,10'-tricyclo[6.2.2.0¹,⁶]dodecan]-11'-yl 2-methylpropanoate
1-(acetyloxy)-1-[11-(acetyloxy)-7-hydroxy-4-methyl-9-methylidene-5,12-dioxatricyclo[8.4.0.0⁴,⁶]tetradec-13-en-14-yl]-4-methylpent-3-en-2-yl acetate
(1s,2s,3r,5s,8r,9r,10r)-9,10-bis(acetyloxy)-1,5-dihydroxy-8,12,15,15-tetramethyl-4-methylidene-13-oxotricyclo[9.3.1.0³,⁸]pentadec-11-en-2-yl acetate
(1s,2s,4r,5s,7r,8s,10s,11s,12s,14r,16s)-7,8-bis(acetyloxy)-14,16-dihydroxy-6,6,10-trimethyl-15-methylidene-3-oxapentacyclo[12.2.1.0¹,¹¹.0²,⁴.0⁵,¹⁰]heptadecan-12-yl acetate
(1e,3r,4s,6s,9r,11s,12s,14s)-9,12-bis(acetyloxy)-3,14-dihydroxy-7,11,16,16-tetramethyl-10-oxotricyclo[9.3.1.1⁴,⁸]hexadeca-1,7-dien-6-yl acetate
2,10-bis(acetyloxy)-7-hydroxy-4,14,16,16-tetramethyl-8-methylidene-13-oxo-15-oxatetracyclo[9.4.1.0¹,¹⁴.0⁴,⁹]hexadecan-3-yl acetate
2-{[(2e,4e,6e,8e,10e)-1-hydroxy-2,10-dimethyl-11-[(4r,5r)-5-methyl-2-[(1e)-2-(1h-pyrrol-2-yl)ethenyl]-4,5-dihydro-1,3-oxazol-4-yl]undeca-2,4,6,8,10-pentaen-1-ylidene]amino}-3-(c-hydroxycarbonimidoyl)propanoic acid
2,10-bis(acetyloxy)-7,13-dihydroxy-4,14,15,15-tetramethyl-3-oxotricyclo[9.3.1.1⁴,⁸]hexadeca-1(14),8-dien-5-yl acetate
5,9-dimethyl 3,10-bis(acetyloxy)-12-isopropyl-1-methyl-15-oxabicyclo[12.1.0]pentadeca-4,8,12-triene-5,9-dicarboxylate
(2r,3e)-5-(3-chloro-5-formyl-2,6-dihydroxy-4-methylphenyl)-3-methyl-1-[(1r,2s,6s)-1,2,6-trimethyl-3-oxocyclohexyl]pent-3-en-2-yl butanoate
(1r,2s)-1-[(1r,4as,8s,9r,11ar)-1-(acetyloxy)-8,9-dihydroxy-7,11-dimethylidene-1h,4ah,5h,6h,8h,9h,10h,11ah-cyclonona[c]pyran-4-yl]-1-(acetyloxy)-4-methylpent-3-en-2-yl acetate
(1r,3r,4r,5r,7s,10r,11r,12r,14r)-11,12-bis(acetyloxy)-1,7-dihydroxy-10,14,17-trimethyl-6-methylidene-16-oxatetracyclo[11.3.1.0³,¹⁴.0⁵,¹⁰]heptadec-13(17)-en-4-yl acetate
2,7-bis(acetyloxy)-5-[2-(furan-3-yl)ethyl]-8-hydroxy-5,6-dimethyl-hexahydro-2h-spiro[naphthalene-1,2'-oxiran]-8a-ylmethyl acetate
(7z,11e)-5,9-bis(acetyloxy)-17-hydroxy-4,8,12-trimethyl-16-methylidene-3,18-dioxatricyclo[13.3.0.0²,⁴]octadeca-7,11-dien-14-yl acetate
2,6-bis(acetyloxy)-8,11-dihydroxy-5,5,9-trimethyl-14-methylidene-15-oxotetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecan-3-yl acetate
(2r,4r,6s,11s)-2,8-bis(acetyloxy)-3,6-dihydroxy-5,5,9-trimethyl-14-methylidene-15-oxotetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecan-11-yl acetate
(1e,3r,4r,6s,9r,11s,12s,14s)-3,12-bis(acetyloxy)-9,14-dihydroxy-7,11,16,16-tetramethyl-10-oxotricyclo[9.3.1.1⁴,⁸]hexadeca-1,7-dien-6-yl acetate
[(1s)-2-(2-{[(1s,2s,3s,7as)-1,7-dihydroxy-3,7a-dimethyl-5-[(3-methylbut-2-enoyl)imino]-2,3-dihydro-1h-pyrrolizin-2-yl]sulfanyl}-3h-imidazol-4-yl)-1-carboxyethyl]trimethylazanium
[C23H34N5O5S]+ (492.2280534000001)